BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4167406)

  • 1. Studies on the nature of plasma thyroid stimulating activity in hyperthyroidism.
    Hoffman MJ; Mason EK; Good BF; Hetzel BS; Ferguson K
    Australas Ann Med; 1967 May; 16(2):98-106. PubMed ID: 4167406
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of long-acting thyroid stimulator globulin (LATS) and serum to stimulate thyroid function in the chick.
    Lepp A; Oliner L
    Endocrinology; 1967 Feb; 80(2):369-74. PubMed ID: 4163488
    [No Abstract]   [Full Text] [Related]  

  • 3. Positive correlation of the long-acting thyroid stimulator (LATS) with the percentage of endogenously labelled 131 I triiodothyronine in the plasma of hyperthyroid patients.
    Emrich D; Albani M; zur Mühlen A von
    Acta Endocrinol (Copenh); 1971 Nov; 68(3):445-50. PubMed ID: 4107957
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical significance of LATS and TSH in the blood.
    Lemarchand-Béraud T; Griessen M; Scazziga BR
    Ann Clin Res; 1972 Jun; 4(3):121-37. PubMed ID: 4625026
    [No Abstract]   [Full Text] [Related]  

  • 5. Measurements of the thyroid-stimulating hormone content of serum from hypothyroid and euthyroid people.
    Adams DD; Kennedy TH
    J Clin Endocrinol Metab; 1968 Mar; 28(3):325-31. PubMed ID: 5642686
    [No Abstract]   [Full Text] [Related]  

  • 6. THYROTROPIN AND LONG-ACTING THYROID STIMULATOR ASSAYS IN THYROID DISEASE.
    PINCHERA A; PINCHERA MG; STANBURY JB
    J Clin Endocrinol Metab; 1965 Feb; 25():189-208. PubMed ID: 14264241
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
    Lamberg BA; Gordin A
    Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyroid-stimulating autoantibodies.
    Adams DD
    Vitam Horm; 1980; 38():119-203. PubMed ID: 6291240
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biological determination of thyrotropin and long-acting thyroid simulator].
    Potin VV; Stepanov GS
    Probl Endokrinol (Mosk); 1969; 15(4):64-7. PubMed ID: 5395630
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of thyrotropic hormone and long acting thyroid stimulator by the McKenzie technique. Critical study of the method].
    Bonnyns M
    Rev Fr Etud Clin Biol; 1968 Nov; 13(9):845-52. PubMed ID: 5709509
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma thyrotropin (TSH) and long-acting thyroid stimulator (LATS) in patients treated for thyroid carcinoma.
    Valenta L; Lemarchand-Béraud T; Vannotti A
    Eur J Cancer (1965); 1970 Apr; 6(2):139-43. PubMed ID: 5450187
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-acting thyroid stimulator in euthyroid relatives of thyrotoxic patients.
    Wall JR; Good BF; Hetzel BS
    Lancet; 1969 Nov; 2(7629):1024-6. PubMed ID: 4187540
    [No Abstract]   [Full Text] [Related]  

  • 13. EVIDENCE OF A NORMALLY FUNCTIONING PITUITARY TSH SECRETION MECHANISM IN A PATIENT WITH A HIGH BLOOD LEVEL OF LONG-ACTING THYROID STIMULATOR.
    ADAMS DD; KENNEDY TH
    J Clin Endocrinol Metab; 1965 May; 25():571-6. PubMed ID: 14313750
    [No Abstract]   [Full Text] [Related]  

  • 14. Neutralization of "long-acting thyroid stimulator" of Graves' disease by antisera to bovine pituitary thyrotropin.
    WERNER SC; TIERNEY J
    Proc Soc Exp Biol Med; 1961 Dec; 108():780-4. PubMed ID: 14006235
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperthyroidism and demonstration of circulating long-acting thyroid stimulator following hypophysectomy for chromophobe adenoma.
    Burke G
    J Clin Endocrinol Metab; 1967 Aug; 27(8):1161-6. PubMed ID: 4166582
    [No Abstract]   [Full Text] [Related]  

  • 16. The immunoassay of thyroid-stimulating hormone and its clinical applications.
    Hall R
    Clin Endocrinol (Oxf); 1972 Jan; 1(1):115-25. PubMed ID: 4200175
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of the long-acting thyroid stimulator protector with the immunoglobulin G fraction of serum from patients with thyrotoxicosis.
    Dirmikis SM; Justice SK; Munro DS
    Biochim Biophys Acta; 1975 Jan; 379(1):239-46. PubMed ID: 1115798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro procedure for the estimation of thyroid hormone releasing factors in sera of thyrotoxic patients.
    Maayan ML; Volpert EM; Dawry FP
    J Endocrinol Invest; 1978 Oct; 1(4):299-304. PubMed ID: 92490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Etiology of hyperthyroidism].
    Lemarchand-Béraud T; Vannotti A; Griessen M
    Schweiz Med Wochenschr; 1967 Oct; 97(41):1342-52. PubMed ID: 5631864
    [No Abstract]   [Full Text] [Related]  

  • 20. IMMUNOLOGICAL STUDIES ON THE LONG-ACTING THYROID STIMULATOR.
    DORRINGTON KJ; MUNRO DS
    Clin Sci; 1965 Feb; 28():165-74. PubMed ID: 14256898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.